CytoPherx, Inc., founded in July 2007 and headquartered in Ann Arbor, Michigan, is a venture-backed, clinical stage medical device company addressing inflammation-based diseases and conditions with a proprietary selective cytopheresis system.
|
This page is a "seed" This page about a business is a placeholder and may have little to no useful information. You can help Arborwiki by clicking the edit button and adding as much as you can. If you think this article has reached the point where it's grown beyond being a first start, please remove {{biz-stub}} from the article. |
